Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jacob George

Showing results (101-110 of 971) with videos related to

Pageof 98
Sort By:
Clinical Liver Disease|January 25, 2021
NAFLD in Lean AsiansMohammed Eslam, Fei Chen, Jacob George
Hospital Medicine (London, England : 1998)|March 3, 2005
Non-alcoholic fatty liver diseaseIan Homer Y Cua, Jacob George
International Journal of General Medicine|May 11, 2013
Getting it right: the impact of a continuing medical education program on hepatitis B knowledge of Australian primary care providersMonica Robotin, Yumi Patton, Jacob George
Foot & Ankle International|December 6, 2006
Blood flow to the metatarsal head after chevron bunionectomyJoby Jacob George Malal, Bobin Varghese
Journal of Hepatology|January 16, 2021
Yet more evidence that MAFLD is more than a name changeMohammed Eslam, Vlad Ratziu, Jacob George
The British Journal of Cardiology|September 9, 2024
Efficacy and tolerability of PCSK9 inhibitors in real-world clinical practicePrashasthi Devaiah, Sava Handjiev, Jacob George
Gastroenterology|February 12, 2020
MAFLD: A Consensus-Driven Proposed Nomenclature for Metabolic Associated Fatty Liver DiseaseMohammed Eslam, Arun J Sanyal, Jacob George, et al.
International Journal of Cardiology|April 30, 2014
The source of BNP in rheumatoid arthritisJacob George, F Khan, A D Struthers
Harefuah|June 30, 2006
[Endothelial progenitor cells (EPCs)--new tools for diagnosis and therapy]Jeremy Ben-Shoshan, Gad Keren, Jacob George
Alimentary Pharmacology & Therapeutics|September 25, 2018
Editorial: STAT-4 polymorphism - a tool to personalise clinical practice in chronic HBV infection. Authors' replyRasha El Sharkawy, Jacob George, Mohammed Eslam
Pageof 98

Showing results (101-110 of 971) with videos related to

Sort By:
Pageof 98
Clinical Liver Disease|January 25, 2021
NAFLD in Lean AsiansMohammed Eslam, Fei Chen, Jacob George
Hospital Medicine (London, England : 1998)|March 3, 2005
Non-alcoholic fatty liver diseaseIan Homer Y Cua, Jacob George
International Journal of General Medicine|May 11, 2013
Getting it right: the impact of a continuing medical education program on hepatitis B knowledge of Australian primary care providersMonica Robotin, Yumi Patton, Jacob George
Foot & Ankle International|December 6, 2006
Blood flow to the metatarsal head after chevron bunionectomyJoby Jacob George Malal, Bobin Varghese
Journal of Hepatology|January 16, 2021
Yet more evidence that MAFLD is more than a name changeMohammed Eslam, Vlad Ratziu, Jacob George
The British Journal of Cardiology|September 9, 2024
Efficacy and tolerability of PCSK9 inhibitors in real-world clinical practicePrashasthi Devaiah, Sava Handjiev, Jacob George
Gastroenterology|February 12, 2020
MAFLD: A Consensus-Driven Proposed Nomenclature for Metabolic Associated Fatty Liver DiseaseMohammed Eslam, Arun J Sanyal, Jacob George, et al.
International Journal of Cardiology|April 30, 2014
The source of BNP in rheumatoid arthritisJacob George, F Khan, A D Struthers
Harefuah|June 30, 2006
[Endothelial progenitor cells (EPCs)--new tools for diagnosis and therapy]Jeremy Ben-Shoshan, Gad Keren, Jacob George
Alimentary Pharmacology & Therapeutics|September 25, 2018
Editorial: STAT-4 polymorphism - a tool to personalise clinical practice in chronic HBV infection. Authors' replyRasha El Sharkawy, Jacob George, Mohammed Eslam
Pageof 98